Drug Review on PPIs – Proton Pump Inhibitors (Antacids) with Risk of CDAD – Clostridium Difficile Associated Diarrhea
The FDA is alerting gastroenerologists, general family practitioners and consumers on findings of the drug review for PPIs – Proton Pump Inhibitors, as well as H2RAs – Histamine H2 Receptor Antagonists which have elicited, or are under review, for the enhanced health risk of CDAD – Clostridium Difficile Associated Diarrhea. FDA Alert on Stomach Acid [...]
Read more
Recent Comments